<unk>  is an chemotherapeutic adjuvant that is FDA approved for the treatment of after high-dose methotrexate therapy in osteosarcoma and also indicated to diminish the toxicity and counteract the effects of impaired methotrexate  elimination and of inadvertent overdosage of folic acid antagonists.   Common adverse reactions include alopecia , dermatitis, diarrhea, loss of appetite , nausea , stomatitis, hypersensitivity reaction.
Levoleucovorin
Leucovorin 
Darbepoetin alfa
Darbepoetin Alfa
Galsulfase
Oxydisulfoton
Indigotindisulfonate
Strontium ranelate